Librarian View

LEADER 05047cam a22006255i 4500
001 13629802
005 20200729062852.0
006 m o d
007 cr nn 008mamaa
008 180510s2018 gw | o |||| 0|eng d
020
  
  
|a 9783319668338
024
7
  
|a 10.1007/978-3-319-66833-8 |2 doi
035
  
  
|a (DE-He213)978-3-319-66833-8
035
  
  
|a 13629802
050
  
4
|a HD28-70
072
  
7
|a KJMV6 |2 bicssc
072
  
7
|a PDG |2 bicssc
072
  
7
|a BUS087000 |2 bisacsh
082
0
4
|a 658.514 |2 23
100
1
  
|a Gassmann, Oliver.
245
1
0
|a Leading Pharmaceutical Innovation |h [electronic resource] : |b How to Win the Life Science Race / |c by Oliver Gassmann, Alexander Schuhmacher, Max von Zedtwitz, Gerrit Reepmeyer.
250
  
  
|a 3rd ed. 2018.
264
  
1
|a Cham : |b Springer International Publishing : |b Imprint: Springer, |c 2018.
300
  
  
|a 1 online resource (XV, 179 p.) 41 illus., 3 illus. in color.
336
  
  
|a text |b txt |2 rdacontent
337
  
  
|a computer |b c |2 rdamedia
338
  
  
|a online resource |b cr |2 rdacarrier
347
  
  
|a text file |b PDF |2 rda
505
0
  
|a Innovation: Key to Success in the Pharmaceutical Industry -- The Industry Challenge: Who Would Want to Be in This Business?- The Science and Technology Challenge: How to Find New Drugs -- The Pipeline Challenge: How to Organize Innovation -- The Make-or-Buy Challenge: How to In- and Outsource Innovation -- The Open Innovation Challenge: How to Partner for Innovation -- The Internationalization Challenge: Where to Access Innovation -- Future Directions and Trends.
506
  
  
|a Access restricted by licensing agreement.
520
  
  
|a This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. New models and methods are illustrated with cases from Europe, the US, and Asia. This third fully revised edition was expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture capital and early-stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation. Health care innovation is possibly the greatest opportunity and challenge of our generation. This important book shows how pharmaceutical companies will continue to play an instrument role in making our lives better. Stefan Thomke, William Barclay Harding Professor of Business Administration, Harvard Business School Very comprehensive review and analysis of current challenges for the biopharmaceutical industry. To stay competitive in this new technology driven environment, the industry started to develop new partnership models to close the innovation gap and provide patients with the relevant healthcare toolkits at the convergence of pharmaceuticals, diagnostics and IT technologies. Very exciting times ahead well depicted in this book! Karima Boubekeur, VP Emerging Portfolio and Search & Evaluation, AstraZeneca Great. The 3rd edition is not only an update. It’s an outstandingly featured summary on the challenges of pharma innovation. Eckard von Keutz, SVP and Head of Early Development, Bayer Healthcare.
590
  
  
|a Access is available to the Yale community.
650
  
0
|a Business. |0 http://id.loc.gov/authorities/subjects/sh85018260
650
  
0
|a Pharmacy. |0 http://id.loc.gov/authorities/subjects/sh85100603
650
  
0
|a Management. |0 http://id.loc.gov/authorities/subjects/sh85080336
650
  
0
|a Industrial management. |0 http://id.loc.gov/authorities/subjects/sh85065889
650
  
0
|a Health services administration. |0 http://id.loc.gov/authorities/subjects/sh85059600
650
  
0
|a Pharmaceutical technology. |0 http://id.loc.gov/authorities/subjects/sh85100590
650
  
0
|a Pharmacy management. |0 http://id.loc.gov/authorities/subjects/sh85100621
650
  
0
|a Medical economics. |0 http://id.loc.gov/authorities/subjects/sh85082915
700
1
  
|a Schuhmacher, Alexander. |0 http://id.loc.gov/authorities/names/nb2018008578
700
1
  
|a von Zedtwitz, Max.
700
1
  
|a Reepmeyer, Gerrit.
710
2
  
|a SpringerLink (Online service) |0 http://id.loc.gov/authorities/names/no2005046756
730
0
  
|a Springer ebooks.
773
0
  
|t Springer eBooks
776
0
8
|i Printed edition: |z 9783319668321
852
8
0
|z Online resource
856
4
0
|y Online book |u https://yale.idm.oclc.org/login?URL=http://dx.doi.org/10.1007/978-3-319-66833-8
901
  
  
|a HD28-70
902
  
  
|a Yale Internet Resource |b Yale Internet Resource >> None|DELIM|13659959
905
  
  
|a online resource
907
  
  
|a 2018-05-31T09:59:01.000Z
946
  
  
|a DO NOT EDIT. DO NOT EXPORT.
953
4
0
|a http://dx.doi.org/10.1007/978-3-319-66833-8